Ensysce Biosciences, Inc. - ENSC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$455K
QoQ value delta ($000)
-$370K (-44.85%)
Implied price effect (QoQ)
-61.41%
Shares
Total shares
502,620
QoQ shares delta
+150,921 (+42.91%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ENSC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 18 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ADAGE CAPITAL PARTNERS GP, L.L.C. 137 149,711 0.0%
DRW Securities, LLC 90 98,481 0.0%
PERCEPTIVE ADVISORS LLC 79 86,666 0.0%
VANGUARD GROUP INC 33 36,708 0.0%
HRT FINANCIAL LP 22 24,491 0.0%
Financial Plan, Inc. 22 24,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 20 22,090 0.0%
TWO SIGMA SECURITIES, LLC 19 21,605 0.0%
Williams & Novak, LLC 16 17,850 0.01%
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 11 12,000 0.01%
Tower Research Capital LLC (TRC) 4 5,319 0.0%
FNY Investment Advisers, LLC 2 3,000 0.0%
BANK OF AMERICA CORP /DE/ 0 72 0.0%
JONES FINANCIAL COMPANIES LLLP 0 41 0.0%
UBS Group AG 0 100 0.0%
SBI Securities Co., Ltd. 0 421 0.0%
BlackRock, Inc. 0 65 0.0%